https://www.selleckchem.com/pr....oducts/lomeguatrib.h
4 % and 20.0 % respectively, with a significant statistical difference (p 0.05). For those HC patients of Bismuth III/IV, the infection rates under ERCP and PTCD procedure were 58.3 % and 14.3 %, respectively (p 0.05). both PTCD and ERCP with SEMS implantation were effective to prolong the survival time of HC patients. The biliary infection rates were higher in the ERCP group, especially for Bismuth III/IV HC patients. both PTCD and ERCP with SEMS implantation were effective to prolong the survival time of HC patients. The
إعجاب
علق
شارك
